The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas

C. S. Park, E. A. Wiebke, R. A. Sidner, G. A. Miller, Oscar Cummings, Thomas Howard, N. S. Fineberg, J. A. Madura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Carcinoma of the pancreas is a leading cause of cancer mortality in the United States. Improvement in prediction of survival is needed. Flow cytometric analysis as a prognostic tool has produced conflicting results. We retrospectively analyzed the clinicopathologic features, operative factors, and outcome of 39 curative resections for ductal adenocarcinoma of the head of the pancreas performed at Indiana University Medical Center between 1989 and 1994. The group was composed of 20 females and 19 males. Procedures performed were Whipple without vagotomy (n = 5), Whipple with vagotomy (n = 19), pylorus-preserving Whipple (n = 12) and total pancreatectomy (n = 3). Thirty-two tumors were suitable for DNA analysis. Of the 32 patients with flow cytometric data, 33 per cent (3/9) of living patients and 39 per cent (9/23) of deceased patients had aneuploid tumors (P = 0.999). The average S-phase for living patients was 8.3 per cent ± 3.8 per cent, and 16.1 per cent ± 13.6 per cent for deceased patients (P = 0.115). In the multivariate analysis, only lymphatic invasion (P = 0.015) and alkaline phosphatase level (P = 0.024) predicted poor survival. Our data show no correlation between flow cytometric DNA ploidy, S-phase analysis, and prognosis in patients undergoing curative resection for ductal adenocarcinoma of the pancreatic head.

Original languageEnglish
Pages (from-to)609-615
Number of pages7
JournalAmerican Surgeon
Volume62
Issue number7
StatePublished - Jul 1996

Fingerprint

Pancreas
Adenocarcinoma
DNA
Vagotomy
S Phase
Neoplasms
Pancreatectomy
Survival
Ploidies
Pylorus
Aneuploidy
Alkaline Phosphatase
Multivariate Analysis
Carcinoma
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas. / Park, C. S.; Wiebke, E. A.; Sidner, R. A.; Miller, G. A.; Cummings, Oscar; Howard, Thomas; Fineberg, N. S.; Madura, J. A.

In: American Surgeon, Vol. 62, No. 7, 07.1996, p. 609-615.

Research output: Contribution to journalArticle

Park, CS, Wiebke, EA, Sidner, RA, Miller, GA, Cummings, O, Howard, T, Fineberg, NS & Madura, JA 1996, 'The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas', American Surgeon, vol. 62, no. 7, pp. 609-615.
Park, C. S. ; Wiebke, E. A. ; Sidner, R. A. ; Miller, G. A. ; Cummings, Oscar ; Howard, Thomas ; Fineberg, N. S. ; Madura, J. A. / The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas. In: American Surgeon. 1996 ; Vol. 62, No. 7. pp. 609-615.
@article{d33fd134a5fb4e9687c1c0e26ff0e00e,
title = "The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas",
abstract = "Carcinoma of the pancreas is a leading cause of cancer mortality in the United States. Improvement in prediction of survival is needed. Flow cytometric analysis as a prognostic tool has produced conflicting results. We retrospectively analyzed the clinicopathologic features, operative factors, and outcome of 39 curative resections for ductal adenocarcinoma of the head of the pancreas performed at Indiana University Medical Center between 1989 and 1994. The group was composed of 20 females and 19 males. Procedures performed were Whipple without vagotomy (n = 5), Whipple with vagotomy (n = 19), pylorus-preserving Whipple (n = 12) and total pancreatectomy (n = 3). Thirty-two tumors were suitable for DNA analysis. Of the 32 patients with flow cytometric data, 33 per cent (3/9) of living patients and 39 per cent (9/23) of deceased patients had aneuploid tumors (P = 0.999). The average S-phase for living patients was 8.3 per cent ± 3.8 per cent, and 16.1 per cent ± 13.6 per cent for deceased patients (P = 0.115). In the multivariate analysis, only lymphatic invasion (P = 0.015) and alkaline phosphatase level (P = 0.024) predicted poor survival. Our data show no correlation between flow cytometric DNA ploidy, S-phase analysis, and prognosis in patients undergoing curative resection for ductal adenocarcinoma of the pancreatic head.",
author = "Park, {C. S.} and Wiebke, {E. A.} and Sidner, {R. A.} and Miller, {G. A.} and Oscar Cummings and Thomas Howard and Fineberg, {N. S.} and Madura, {J. A.}",
year = "1996",
month = "7",
language = "English",
volume = "62",
pages = "609--615",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "7",

}

TY - JOUR

T1 - The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas

AU - Park, C. S.

AU - Wiebke, E. A.

AU - Sidner, R. A.

AU - Miller, G. A.

AU - Cummings, Oscar

AU - Howard, Thomas

AU - Fineberg, N. S.

AU - Madura, J. A.

PY - 1996/7

Y1 - 1996/7

N2 - Carcinoma of the pancreas is a leading cause of cancer mortality in the United States. Improvement in prediction of survival is needed. Flow cytometric analysis as a prognostic tool has produced conflicting results. We retrospectively analyzed the clinicopathologic features, operative factors, and outcome of 39 curative resections for ductal adenocarcinoma of the head of the pancreas performed at Indiana University Medical Center between 1989 and 1994. The group was composed of 20 females and 19 males. Procedures performed were Whipple without vagotomy (n = 5), Whipple with vagotomy (n = 19), pylorus-preserving Whipple (n = 12) and total pancreatectomy (n = 3). Thirty-two tumors were suitable for DNA analysis. Of the 32 patients with flow cytometric data, 33 per cent (3/9) of living patients and 39 per cent (9/23) of deceased patients had aneuploid tumors (P = 0.999). The average S-phase for living patients was 8.3 per cent ± 3.8 per cent, and 16.1 per cent ± 13.6 per cent for deceased patients (P = 0.115). In the multivariate analysis, only lymphatic invasion (P = 0.015) and alkaline phosphatase level (P = 0.024) predicted poor survival. Our data show no correlation between flow cytometric DNA ploidy, S-phase analysis, and prognosis in patients undergoing curative resection for ductal adenocarcinoma of the pancreatic head.

AB - Carcinoma of the pancreas is a leading cause of cancer mortality in the United States. Improvement in prediction of survival is needed. Flow cytometric analysis as a prognostic tool has produced conflicting results. We retrospectively analyzed the clinicopathologic features, operative factors, and outcome of 39 curative resections for ductal adenocarcinoma of the head of the pancreas performed at Indiana University Medical Center between 1989 and 1994. The group was composed of 20 females and 19 males. Procedures performed were Whipple without vagotomy (n = 5), Whipple with vagotomy (n = 19), pylorus-preserving Whipple (n = 12) and total pancreatectomy (n = 3). Thirty-two tumors were suitable for DNA analysis. Of the 32 patients with flow cytometric data, 33 per cent (3/9) of living patients and 39 per cent (9/23) of deceased patients had aneuploid tumors (P = 0.999). The average S-phase for living patients was 8.3 per cent ± 3.8 per cent, and 16.1 per cent ± 13.6 per cent for deceased patients (P = 0.115). In the multivariate analysis, only lymphatic invasion (P = 0.015) and alkaline phosphatase level (P = 0.024) predicted poor survival. Our data show no correlation between flow cytometric DNA ploidy, S-phase analysis, and prognosis in patients undergoing curative resection for ductal adenocarcinoma of the pancreatic head.

UR - http://www.scopus.com/inward/record.url?scp=0030011566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030011566&partnerID=8YFLogxK

M3 - Article

C2 - 8651561

AN - SCOPUS:0030011566

VL - 62

SP - 609

EP - 615

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 7

ER -